Dr. Reddy's Laboratories Limited
RDY
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that areā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
24 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$13.74
Price-2.14%
-$0.30
1Y
Price
Market Cap
$11.434b
Large
Price/Earnings 3y Avg5y Avg
17.6x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in INR.+27.6%
EBITDA Margin+16.3%
Net Profit Margin+6.2%
Free Cash Flow Margin+27.6%
EBITDA Margin+16.3%
Net Profit Margin+6.2%
Free Cash Flow MarginRevenue
$342.149b
+5.1%
1y CAGR+11.8%
3y CAGR+12.5%
5y CAGREarnings
$58.621b
+3.7%
1y CAGR+9.6%
3y CAGR+30.0%
5y CAGREPS
$70.31
+3.8%
1y CAGR+9.5%
3y CAGR+29.9%
5y CAGRBook Value
$362.082b
$542.005b
Assets$179.923b
Liabilities$58.539b
DebtDebt to Assets
10.8%
0.6x
Debt to EBITDAFree Cash Flow
$18.471b
+53.5%
1y CAGR-11.5%
3y CAGR+76.8%
5y CAGRNo items found.
Press Releases
Statements and updates from the company